scholarly journals Clinical Outcomes and Prognostic Factors of Salvage Treatment for Local Lymph Node Recurrence After Radical Resection of Oesophageal Carcinoma

2021 ◽  
Vol Volume 13 ◽  
pp. 5845-5853
Author(s):  
Liang Gu ◽  
Yangchen Liu ◽  
Hongxue Ye ◽  
Fei Gao ◽  
Xiaoxiang Yin ◽  
...  
2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Jie Chen ◽  
Wenming Yin ◽  
Hui Yao ◽  
Wendong Gu

Abstract Background Patients with regional lymph node recurrence after radical resection of esophageal cancer have poor therapeutic outcomes. Currently, there is no standard treatment for regional lymph node recurrence, and its prognostic risk factors are not well-understood. This study retrospectively analyzed 83 patients with postoperative regional lymph node recurrence after radical resection of esophageal squamous cell carcinoma. The aim was to evaluate the clinical efficacy and prognostic factors of salvage radiotherapy with or without chemotherapy in these patients. Methods The survival and prognostic factors of 83 patients with esophageal squamous cell carcinoma with regional lymph node recurrence after radical surgery were retrospectively analyzed. All patients underwent radiotherapy, of which 74 patients received volumetric modulated arc therapy (VMAT), 9 patients received three-dimensional conformal radiation therapy (3DCRT), administered using a conventional segmentation protocol with a dose distribution range of 50.4–66.2Gy (median dose of 60Gy). In total, 41 patients received radiotherapy alone, 42 received radiotherapy combined with chemotherapy, and the concurrent chemotherapy regimen was mainly composed of either platinum or fluorouracil monotherapy, except for 4 patients who were given 5-fluorouracil plus platinum (FP) or paclitaxel plus platinum (TP). Results The median follow-up time was 24 (range, 9–75) months. The overall survival (OS) rates at 1 year, 2 years, 3 years, and 5 years were 83.0, 57.1, 40.1, and 35.1%, respectively. The median overall survival (OS) time was 18 (range, 5–75) months. The 3-year survival rate was 47.5% in patients with radiation alone and 41.9% in patients receiving concurrent chemoradiotherapy(p = 0.570), while the response rate (CR + PR) in those two groups was 73.2 and 91.4%, respectively. By multivariate analysis of OS, age (worse in younger patients, p = 0.034) was found to be significantly associated with disease prognosis. The commonly toxicities were esophagitis, neutropenia and anemia. 18% patients experienced grade 3 toxicity and no treatment-related death occurred. Conclusions These results of this retrospective analysis suggest that radiotherapy with or without chemotherapy is an effective and feasible salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.


2021 ◽  
Vol 44 (1) ◽  
pp. 241-246
Author(s):  
Xing Huang ◽  
Hao Liu ◽  
Xiangqi Liao ◽  
Zhigang Xiao ◽  
Zhongcheng Huang ◽  
...  

2019 ◽  
Vol 39 (6) ◽  
pp. 3147-3157
Author(s):  
JEANNY KWON ◽  
YOUNG A. KIM ◽  
CHEOL LEE ◽  
BYOUNG HYUCK KIM ◽  
SUZY KIM ◽  
...  

2011 ◽  
Vol 123 (2) ◽  
pp. 253-256 ◽  
Author(s):  
Kung-Chu Ho ◽  
Chun-Chieh Wang ◽  
Jian-Tai Qiu ◽  
Chyong-Huey Lai ◽  
Ji-Hong Hong ◽  
...  

2015 ◽  
Vol 115 ◽  
pp. S288
Author(s):  
G. Sancho Pardo ◽  
D. Hernandez ◽  
D. Salas ◽  
D. Giménez ◽  
P. Buitrago ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document